Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05568368
Other study ID # 22Infectio01
Secondary ID
Status Completed
Phase
First received
Last updated
Start date March 15, 2022
Est. completion date September 15, 2022

Study information

Verified date October 2022
Source Centre Hospitalier Universitaire de Nice
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

determination if time-to-detection in cultures of M. tuberculosis samples is more discriminating than acid-fast staining in transmission


Recruitment information / eligibility

Status Completed
Enrollment 705
Est. completion date September 15, 2022
Est. primary completion date September 15, 2022
Accepts healthy volunteers No
Gender All
Age group 2 Years to 94 Years
Eligibility Inclusion Criteria: - have at least 1 contact case explored for tuberculosis - latent tuberculosis infection Exclusion Criteria: -

Study Design


Intervention

Other:
No intervention
no intervention

Locations

Country Name City State
France Nice University Hospital Nice

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire de Nice

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary tuberculosis transmission duration of Tuberculosis transmission between an infected person and a contact case 2 months
Primary contact case tracking screening time for contact cases 2 months
See also
  Status Clinical Trial Phase
Completed NCT04085133 - Prevalence and Burden of Bronchiectasis in Tuberculous Patients
Recruiting NCT05017324 - Sequencing Mycobacteria and Algorithm-determined Resistant Tuberculosis Treatment Trial N/A
Completed NCT04207112 - Economic Evaluation of New MDR TB Regimens Phase 2/Phase 3
Completed NCT04044001 - BTZ-043 - Multiple Ascending Dose (MAD) to Evaluate Safety, Tolerability and Early Bactericidal Activity (EBA) Phase 1/Phase 2
Withdrawn NCT03159975 - Safety and Immunogenicity Study of GX-70 in TB Patient Phase 1
Completed NCT02984579 - Line Probe Assay Evaluation Study N/A
Recruiting NCT04930978 - Effect of SARS-CoV-2 Disease on Immune Responses, Disease Severity and Treatment Outcomes in Pulmonary Tuberculosis
Not yet recruiting NCT05477966 - A Retrospective Cohort Study to Develop Markers for TB Severity and Treatment Progress
Completed NCT05097638 - Lung Health After Tuberculosis: Clinical and Functional Assessment in Post Pulmonary Tuberculosis Egyptian Patients.
Active, not recruiting NCT05045391 - Pulmonary Aspergillosis in Tuberculosis Patients
Completed NCT02754765 - Evaluating Newly Approved Drugs for Multidrug-resistant TB Phase 3
Active, not recruiting NCT03896685 - Evaluating Newly Approved Drugs in Combination Regimens for Multidrug-Resistant TB With Fluoroquinolone Resistance (endTB-Q) Phase 3